Syros CEO, chief scientist out as company cuts staff, programs


The founding CEO of Syros Pharmaceuticals Inc. is departing after 11 years as the company lays off about one-third of its workforce and cuts drug programs.

Previous Wisconsin startup wins contracts at 'Shark-Tank'-like community health competition
Next Syneos Health replaces CEO with life sciences veteran Colin Shannon days after $7B deal closes